Aetna looking to sell drug benefits business: report

Mon Jul 27, 2009 3:22am EDT

(Reuters) - Health insurer Aetna Inc (AET.N) is looking to sell its pharmacy benefits management (PBM) business, the Wall Street Journal said, citing several people familiar with the matter.

Bankers at Bank of America-Merrill Lynch and Credit Suisse have been shopping around the business, the people told the paper.

The people identified CVS Caremark Corp (CVS.N) and Medco Health Solutions Inc MHS.N as potential buyers, the paper said.

The paper said Aetna's PBM business was also shopped to Express Scripts Inc (ESRX.O) which bought WellPoint Inc.'s (WLP.N) NextRx pharmacy benefits business for $4.68 billion in April.

Aetna could not be immediately reached for comment by Reuters outside regular office hours.

(Reporting by Ajay Kamalakaran in Bangalore; Editing by Anshuman Daga)

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.